Kestra Investment Management LLC Buys 1,181 Shares of Chemed Corporation $CHE

Kestra Investment Management LLC raised its stake in shares of Chemed Corporation (NYSE:CHE) by 64.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,007 shares of the company’s stock after buying an additional 1,181 shares during the period. Kestra Investment Management LLC’s holdings in Chemed were worth $1,287,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Alps Advisors Inc. raised its holdings in Chemed by 32.4% during the third quarter. Alps Advisors Inc. now owns 44,295 shares of the company’s stock valued at $19,833,000 after buying an additional 10,845 shares in the last quarter. Van Berkom & Associates Inc. raised its holdings in Chemed by 33.0% during the third quarter. Van Berkom & Associates Inc. now owns 170,813 shares of the company’s stock valued at $76,480,000 after buying an additional 42,390 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Chemed by 773.5% in the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock valued at $11,324,000 after purchasing an additional 23,436 shares during the last quarter. Envestnet Asset Management Inc. grew its position in shares of Chemed by 6.5% in the third quarter. Envestnet Asset Management Inc. now owns 80,080 shares of the company’s stock valued at $35,855,000 after purchasing an additional 4,865 shares during the last quarter. Finally, Intech Investment Management LLC acquired a new stake in shares of Chemed in the third quarter valued at about $1,429,000. 95.85% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.33% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CHE has been the topic of several research analyst reports. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Oppenheimer lowered their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Royal Bank Of Canada raised their price target on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Finally, Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Saturday. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, Chemed currently has an average rating of “Hold” and an average price target of $501.50.

Chemed Trading Down 0.3%

Shares of NYSE:CHE opened at $438.11 on Wednesday. The company has a market cap of $5.81 billion, a P/E ratio of 23.88, a P/E/G ratio of 1.65 and a beta of 0.54. The stock’s 50-day moving average is $401.79 and its 200-day moving average is $424.94. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $581.20. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85.

Chemed (NYSE:CHE) last released its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. During the same period last year, the business earned $5.63 earnings per share. The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities research analysts predict that Chemed Corporation will post 22.3 earnings per share for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be given a dividend of $0.60 per share. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. Chemed’s dividend payout ratio (DPR) is 13.08%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.